Skip to main content
. 2018 Sep-Oct;44(5):933–946. doi: 10.1590/S1677-5538.IBJU.2018.0012

Table 2. Associations between AGR and clinicopathological characteristics.

Low AGR High AGR p value
Age
≤ 65 48 (69.6) 76 (81.7) 0.091
> 65 21 (30.4) 17 (18.3)
Gender
Female 28 (40.6) 32 (34.4) 0.051
Male 41 (59.4) 61 (65.6)
pT stage
pT1-T2 51 (73.9) 83 (89.2) 0.012
pT3-T4 18 (26.1) 10 (10.8)
Fuhrman grade
1-2 37 (53.6) 64 (68.8) 0.052
3-4 32 (46.4) 29 (31.2)
Collecting system invasion
Yes 13 (18.8) 5 (5.4) 0.01
No 56 (81.2) 88 (94.6)
Microvascular invasion
Yes 6 (8.7) 5 (5.4) 0.531
No 63 (91.3) 88 (94.6)
Tumor necrosis
Yes 22 (31.9) 9 (9.7) 0.001
No 47 (68.1) 84 (90.3)
Albumin (mean ± SD) (g / dL) 4.09 ± 0.38 4.48 ± 0.30 < 0.001
Total protein (mean ± SD) (g / dL) 7.49 ± 0.54 7.25 ± 0.43 0.002
Neutrophil [median (range)] / μL 4880 (2180-13600) 4430 (2560-10900) 0.145
Lymphocyte [median (range)] / μL 1720 (770-3300) 1890 (300-4500) 0.432
Monocyte [median (range)] / μL 520 (100-1331) 517 (220-1260) 0.836
Platelet (mean ± SD) / μL 277037 ± 84525 242693 ± 64773 0.004

AGR = Albumin / globulin ratio; SD = Standard deviation